000 01146 a2200313 4500
005 20250517040213.0
264 0 _c20160614
008 201606s 0 0 eng d
022 _a1879-0712
024 7 _a10.1016/j.ejphar.2015.06.025
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMeijers, Wouter C
245 0 0 _aGalectin-3 and post-myocardial infarction cardiac remodeling.
_h[electronic resource]
260 _bEuropean journal of pharmacology
_cSep 2015
300 _a115-21 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aFibrosis
650 0 4 _aGalectin 3
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aMyocardial Infarction
_xdrug therapy
650 0 4 _aVentricular Remodeling
_xdrug effects
700 1 _avan der Velde, A Rogier
700 1 _aPascual-Figal, Domingo A
700 1 _ade Boer, Rudolf A
773 0 _tEuropean journal of pharmacology
_gvol. 763
_gno. Pt A
_gp. 115-21
856 4 0 _uhttps://doi.org/10.1016/j.ejphar.2015.06.025
_zAvailable from publisher's website
999 _c25007729
_d25007729